JP2021512910A5 - - Google Patents
Info
- Publication number
- JP2021512910A5 JP2021512910A5 JP2020542665A JP2020542665A JP2021512910A5 JP 2021512910 A5 JP2021512910 A5 JP 2021512910A5 JP 2020542665 A JP2020542665 A JP 2020542665A JP 2020542665 A JP2020542665 A JP 2020542665A JP 2021512910 A5 JP2021512910 A5 JP 2021512910A5
- Authority
- JP
- Japan
- Prior art keywords
- cocrystal
- powder
- proline
- ray diffractogram
- approximately
- Prior art date
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023173340A JP2024001167A (ja) | 2018-02-07 | 2023-10-05 | ノボビオシン類似体とプロリンとの共結晶形態 |
| JP2025178611A JP2026012851A (ja) | 2018-02-07 | 2025-10-23 | ノボビオシン類似体とプロリンとの共結晶形態 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862627570P | 2018-02-07 | 2018-02-07 | |
| US62/627,570 | 2018-02-07 | ||
| PCT/US2019/016304 WO2019156907A1 (en) | 2018-02-07 | 2019-02-01 | Co-crystal forms of a novobiocin analog and proline |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023173340A Division JP2024001167A (ja) | 2018-02-07 | 2023-10-05 | ノボビオシン類似体とプロリンとの共結晶形態 |
| JP2025178611A Division JP2026012851A (ja) | 2018-02-07 | 2025-10-23 | ノボビオシン類似体とプロリンとの共結晶形態 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021512910A JP2021512910A (ja) | 2021-05-20 |
| JPWO2019156907A5 JPWO2019156907A5 (https=) | 2022-02-04 |
| JP2021512910A5 true JP2021512910A5 (https=) | 2022-02-04 |
Family
ID=65444361
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542665A Pending JP2021512910A (ja) | 2018-02-07 | 2019-02-01 | ノボビオシン類似体とプロリンとの共結晶形態 |
| JP2023173340A Withdrawn JP2024001167A (ja) | 2018-02-07 | 2023-10-05 | ノボビオシン類似体とプロリンとの共結晶形態 |
| JP2025178611A Pending JP2026012851A (ja) | 2018-02-07 | 2025-10-23 | ノボビオシン類似体とプロリンとの共結晶形態 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023173340A Withdrawn JP2024001167A (ja) | 2018-02-07 | 2023-10-05 | ノボビオシン類似体とプロリンとの共結晶形態 |
| JP2025178611A Pending JP2026012851A (ja) | 2018-02-07 | 2025-10-23 | ノボビオシン類似体とプロリンとの共結晶形態 |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US10717755B2 (https=) |
| EP (1) | EP3749675B1 (https=) |
| JP (3) | JP2021512910A (https=) |
| KR (2) | KR20240155354A (https=) |
| CN (2) | CN112020506B (https=) |
| AR (1) | AR114245A1 (https=) |
| AU (3) | AU2019217821B2 (https=) |
| BR (1) | BR112020016205A2 (https=) |
| CA (2) | CA3226385A1 (https=) |
| CL (2) | CL2020002051A1 (https=) |
| CO (1) | CO2020009761A2 (https=) |
| EA (1) | EA202091885A1 (https=) |
| IL (2) | IL276583B2 (https=) |
| MX (2) | MX2020008326A (https=) |
| MY (1) | MY209803A (https=) |
| PE (1) | PE20211446A1 (https=) |
| SG (1) | SG11202007530XA (https=) |
| TW (2) | TWI797249B (https=) |
| WO (1) | WO2019156907A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3749675B1 (en) | 2018-02-07 | 2025-12-31 | Reata Pharmaceuticals, Inc. | CO-CRISTALLIN FORMS OF A NOVOBIOCIN AND PROLINE ANALOGUE |
| MY204234A (en) | 2018-08-27 | 2024-08-16 | Regeneron Pharma | Use of raman spectroscopy in downstream purification |
| CN115181146B (zh) * | 2021-04-02 | 2024-06-04 | 浙江普洛家园药业有限公司 | 一种新生霉素的提取工艺 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9029369B2 (en) * | 2010-09-23 | 2015-05-12 | Nuformix Limited | Aprepitant L-proline composition and cocrystal |
| TWI542596B (zh) * | 2011-05-09 | 2016-07-21 | 健生藥品公司 | （２ｓ,３ｒ,４ｒ,５ｓ,６ｒ）－２－（３－（（５－（４－氟苯基）噻吩－２－基）甲基）－４－甲基苯基）－６－（羥甲基）四氫－２ｈ－哌喃－３,４,５－三醇之ｌ－脯胺酸及檸檬酸共晶體 |
| CA2892832C (en) * | 2011-11-25 | 2020-04-14 | Nuformix Technologies Limited | Aprepitant l-proline solvates - compositions and cocrystals |
| EP2602249B1 (en) * | 2011-12-06 | 2015-08-12 | F.I.S. Fabbrica Italiana Sintetici S.p.A. | Synthesis of rosuvastatin by means of co-crystals |
| SMT201900660T1 (it) * | 2012-02-09 | 2020-01-14 | Univ Kansas | Inibitori c-terminali di hsp90 |
| EP2890704B1 (en) * | 2012-08-31 | 2018-02-28 | Novartis AG | 2'-ethynyl nucleoside derivatives for treatment of viral infections |
| TW201512201A (zh) * | 2013-03-14 | 2015-04-01 | Forum Pharmaceuticals Inc | 化合物的多晶型及鹽類 |
| MX388516B (es) * | 2014-06-24 | 2025-03-20 | Univ Kansas | Bifenil amidas con grupos éter modificados como inhibidores de hsp90 e inductores de hsp70. |
| KR20170060035A (ko) * | 2014-09-30 | 2017-05-31 | 지앙수 헨그루이 메디슨 컴퍼니 리미티드 | 나트륨 글루코스 공동운반체 2 억제제의 ｌ- 프롤린 화합물, 및 ｌ- 프롤린 화합물의 모노하이드레이트 및 결정 |
| EP3749675B1 (en) | 2018-02-07 | 2025-12-31 | Reata Pharmaceuticals, Inc. | CO-CRISTALLIN FORMS OF A NOVOBIOCIN AND PROLINE ANALOGUE |
-
2019
- 2019-02-01 EP EP19705879.5A patent/EP3749675B1/en active Active
- 2019-02-01 MY MYPI2020004057A patent/MY209803A/en unknown
- 2019-02-01 MX MX2020008326A patent/MX2020008326A/es unknown
- 2019-02-01 US US16/265,256 patent/US10717755B2/en active Active
- 2019-02-01 AU AU2019217821A patent/AU2019217821B2/en active Active
- 2019-02-01 BR BR112020016205-1A patent/BR112020016205A2/pt unknown
- 2019-02-01 CN CN201980011980.6A patent/CN112020506B/zh active Active
- 2019-02-01 JP JP2020542665A patent/JP2021512910A/ja active Pending
- 2019-02-01 CA CA3226385A patent/CA3226385A1/en active Pending
- 2019-02-01 TW TW108104336A patent/TWI797249B/zh active
- 2019-02-01 IL IL276583A patent/IL276583B2/en unknown
- 2019-02-01 PE PE2020001199A patent/PE20211446A1/es unknown
- 2019-02-01 CA CA3090646A patent/CA3090646C/en active Active
- 2019-02-01 CN CN202410935084.1A patent/CN118894894A/zh active Pending
- 2019-02-01 IL IL315865A patent/IL315865A/en unknown
- 2019-02-01 WO PCT/US2019/016304 patent/WO2019156907A1/en not_active Ceased
- 2019-02-01 SG SG11202007530XA patent/SG11202007530XA/en unknown
- 2019-02-01 KR KR1020247033920A patent/KR20240155354A/ko not_active Ceased
- 2019-02-01 EA EA202091885A patent/EA202091885A1/ru unknown
- 2019-02-01 KR KR1020207025571A patent/KR102718111B1/ko active Active
- 2019-02-01 TW TW112106332A patent/TWI868593B/zh active
- 2019-02-05 AR ARP190100277A patent/AR114245A1/es unknown
-
2020
- 2020-06-05 US US16/894,461 patent/US11401294B2/en active Active
- 2020-08-06 MX MX2022012856A patent/MX2022012856A/es unknown
- 2020-08-06 CO CONC2020/0009761A patent/CO2020009761A2/es unknown
- 2020-08-07 CL CL2020002051A patent/CL2020002051A1/es unknown
-
2022
- 2022-12-05 AU AU2022283638A patent/AU2022283638B2/en active Active
- 2022-12-27 CL CL2022003784A patent/CL2022003784A1/es unknown
-
2023
- 2023-02-13 US US18/168,495 patent/US20240043465A1/en not_active Abandoned
- 2023-10-05 JP JP2023173340A patent/JP2024001167A/ja not_active Withdrawn
-
2024
- 2024-10-25 AU AU2024227646A patent/AU2024227646A1/en active Pending
-
2025
- 2025-10-23 JP JP2025178611A patent/JP2026012851A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI839461B (zh) | Il-17a調節物及其用途 | |
| TWI583670B (zh) | Partially saturated nitrogenous heterocyclic compounds | |
| EP1670757B1 (en) | Pyrrole and pyrazole derivatives as potentiators of glutamate receptors | |
| US20240374595A1 (en) | Substituted 1,1'-biphenyl compounds, analogues thereof, and methods using same | |
| TWI299991B (en) | Cetp inhibitors | |
| KR101424013B1 (ko) | 1-(3-시아노-1-아이소프로필-인돌-5-일)피라졸-4-카르복실산의 결정형과 그의 제조방법 | |
| JP2021512910A5 (https=) | ||
| KR20220054293A (ko) | Isoqc 및/또는 qc 효소의 억제제로서 n-치환된-3,4-(융합된 5-환)-5-페닐-피롤리딘-2-온 화합물 | |
| WO2017048962A1 (en) | Hepatitis b core protein modulators | |
| EP3612520B1 (en) | Isoxazole derivatives as nuclear receptor agonists and uses thereof | |
| TW201018460A (en) | Organic compounds and their uses | |
| TW201617316A (zh) | 人類免疫不全症病毒複製之抑制物 | |
| WO2013019653A1 (en) | Compounds and methods | |
| TW201536743A (zh) | Ｍｄｍ２抑制劑之製備方法及結晶型 | |
| CA2546142A1 (en) | Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease | |
| JP6208212B2 (ja) | 呼吸器疾患用薬 | |
| US20080015237A1 (en) | New compounds i/418 | |
| US11155537B2 (en) | Crystal of benzofuran derivative free base and preparation method | |
| US20140288040A1 (en) | Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection | |
| TW200404802A (en) | Xanthine phosphodiesterase V inhibitor polymorphs | |
| JP7158464B2 (ja) | カリウムチャネル阻害剤としての置換ベンゾイミダゾール | |
| US11447470B2 (en) | Pyrimidinone-containing compound, preparation method thereof, pharmaceutical composition and application thereof | |
| JP6758374B2 (ja) | Ｉｄｈ２突然変異を標的とする抗腫瘍化合物及びその使用方法 | |
| CN101821247A (zh) | 作为hsp90抑制剂的抗癌用5-(2-羟基苯基)四唑化合物 | |
| BG107908A (bg) | Инхибитори на фарнезилтрансфераза |